1 / 7

What is the Englis h Yew and how has it developed as an Effective Chemotherapy Agent?

What is the Englis h Yew and how has it developed as an Effective Chemotherapy Agent?. By Amy Evans Economic Botany. Small to medium-sized evergreen tree Reddish-brown trunk with dark, flat leaves Every part of plant is poisonous due to Taxine. English Yew Taxus baccata l.

khanh
Download Presentation

What is the Englis h Yew and how has it developed as an Effective Chemotherapy Agent?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. What is the English Yew and how has it developed as an Effective Chemotherapy Agent? By Amy Evans Economic Botany

  2. Small to medium-sized evergreen tree • Reddish-brown trunk with dark, flat leaves • Every part of plant is poisonous due to Taxine English YewTaxusbaccata l.

  3. Native to the pacific northwest • Extremely slow-growing • Can live for a very long time • One of the only conifers trimmed regularly into hedges

  4. Paclitaxel(Taxol) • Monroe E. Wall and Mansukh C. Wani created the drug from the bark of the English Yew • Mitotic inhibitor • Used in breast, ovarian and lung cancer treatment • Given intravenously (IV) • Annual sales peaked in 2000, reaching $1.6 billion

  5. Side Effects • Low blood counts • Hair loss • Joint and muscle pain (usually resolved within a few days) • Peripheral neuropathy • Nausea/ vomiting (usually mild) • Diarrhea • Mouth sores • Hypersensitivity *all side effects experienced by more than 30% of the experimental group

  6. Studies • The first clinical report was issued in May of 1988 showing a 30% success rate in ovarian cancer patients • Paclitaxel Greenness Project by Bristol-Myers Squibb • Princeton- Ovarian Cancer • Vascular Research Center- Lung cancer (preliminary) • Oxford Journal Study- Head/neck cancer

  7. References • http://www.britannica.com/EBchecked/topic/188318/English-yew • http://www.chemocare.com/bio/paclitaxel.asp • http://pubs.acs.org/cen/coverstory/8228/8228greenchemistry.html • Princeston Study • http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/07-10-2000/0001261714&EDATE= • Vascular Research Center • http://www.vascularweb.org/professionals/Research/Basic_Articles/Neointimal_hyperplasia_clowes.html • Oxford Journal • http://jjco.oxfordjournals.org/cgi/content/full/34/9/499

More Related